PMID: 9436284Jan 1, 1997Paper

Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy

World Journal of Urology
M C BeduschiJ E Oesterling

Abstract

A good staging system should be able to accurately reflect the natural history of a malignant disease, to express the extent of the disease at the time of diagnosis, and stratify patients in prognostically distinctive groups. The staging system for prostate cancer, as it is today, fails to fulfill these requirements. Approximately one third of the patients who undergo surgery for complete excision of prostate cancer in fact do not have a localize disease. The incidence of tumor at the inked margin may reach 30% for T1 stage and up to 60% for clinical T2b prostate cancer according to comparison with pathologic examination of resected specimen. Several concepts have been recently proposed as a means of improving the accuracy of the available staging system. In this paper, we review current aspects of clinical and pathological staging of prostate cancer, and the importance of these new concepts on the early stages of prostate cancer.

References

Mar 1, 1992·The Journal of Urology·M K BrawerP H Lange
Mar 11, 1992·The Journal of Urology·G F DanielsT A Stamey
Jan 1, 1992·The Prostate. Supplement·F H SchröderM Pavone-Macaluso
Mar 1, 1990·British Journal of Urology·R K HaapiainenO S Alfthan
Aug 1, 1990·Mayo Clinic Proceedings·L M RainwaterH Zincke
Apr 25, 1991·The New England Journal of Medicine·W J CatalonaG L Andriole
Aug 1, 1990·Radiology·C H DykeJ M Sweet
Mar 1, 1990·The American Journal of Surgical Pathology·J E McNealT A Stamey
Oct 8, 1987·The New England Journal of Medicine·T A StameyE Redwine
Oct 1, 1989·The Journal of Urology·M A HudsonW J Catalona
Aug 1, 1980·The Journal of Urology·S A KramerD F Paulson
Dec 1, 1980·The Journal of Urology·C B BrendlerD F Paulson
Jan 1, 1994·The Journal of Urology·P Hammerer, H Huland
Nov 1, 1993·British Journal of Urology·M OhoriP T Scardino
Feb 2, 1994·JAMA : the Journal of the American Medical Association·J I EpsteinC B Brendler
Nov 1, 1994·The Journal of Urology·A W Partin, J E Oesterling

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Seminars in Surgical Oncology
D G BostwickJ E Oesterling
Journal of Hepatology
Carlos Rodríguez de LopeJordi Bruix
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jean-Nicolas VautheyDavid M Nagorney
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Nabil P RizkAmerican Joint Committee on Cancer
© 2021 Meta ULC. All rights reserved